手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
5条
与
Organ Sparing Treatments
有关的结果
Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma
2021 年 发布于
Front Oncol
31 卷 第 4 期
Kardoust Parizi M.
Margulis V.
Lotan Y.
Mori K.
Shariat S. F.
Chemotherapy
Adjuvant
*Combined Modality Therapy
Cystectomy
Female
Humans
Middle Aged
Muscles
Neoadjuvant Therapy
*Neoplasm Invasiveness
Organ Sparing Treatments
Patient Selection
Quality of Life
Salvage Therapy
Survival Rate
*Urinary Bladder Neoplasms/therapy
文献简介
原文链接
Sub-Staging-Specific Differences in Recurrence-Free, Progression-Free, and Cancer-Specific Survival for Patients with T1 Bladder Cancer: A Systematic Review and Meta-Analysis
2020 年 发布于
现代泌尿生殖肿瘤杂志
39 卷 第 4 期
Chen G. Q.
Yang T.
Shao Q. Y.
Zhang M. Z.
Yang B.
Zhang P.
Fan J. H.
Cystectomy/*methods
Humans
Organ Sparing Treatments
/*methods
Treatment Outcome
Urinary Bladder Neoplasms/*surgery
Bladder preservation
High-grade non-muscle-invasive bladder cancer
Meta-analysis
Radical cystectomy
PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they
have no competing interests. PUBLISHER’S NOTE: Springer Nature remains neutral
with regard to jurisdictional claims in published maps and institutional
affiliations.
文献简介
原文链接
经尿道激光和传统电切手术治疗非肌层浸润型膀胱肿瘤的 Meta 分析
2019 年 发布于
Gene
68 卷 第 2 期
郭雪涛
Antineoplastic Agents/*therapeutic use
Carcinoma
Transitional Cell/pathology/*therapy
Chemotherapy
Adjuvant
Cystectomy
Cystoscopy
Humans
Lymph Node Excision
Muscle
Smooth/*pathology
*Neoadjuvant Therapy
Neoplasm Invasiveness
*
Organ Sparing Treatments
Progression-Free Survival
Proportional Hazards Models
*Radiotherapy
Adjuvant
Survival Rate
Urinary Bladder Neoplasms/pathology/*therapy
Bladder preserving
Cancer
Muscle invasive
Radical cystectomy
Trimodal
文献简介
原文链接
Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals
2019 年 发布于
Dose-Response
28 卷 第 2 期
Ma J. Y.
Hu G.
Liu Q.
Cystectomy/*methods
Female
Humans
Organ Sparing Treatments
/*methods
Postoperative Complications
Sexual Dysfunction
Physiological/*prevention & control
Treatment Outcome
Urinary Bladder/*pathology
Urinary Bladder Neoplasms/physiopathology/*surgery
Urinary Diversion/*methods
Urinary Incontinence/*prevention & control
#BladderCancer
#blcsm
radical cystectomy
sexual function
urinary bladder neoplasms
urinary incontinence
文献简介
原文链接
Association between obesity and bladder cancer recurrence: A meta-analysis
2018 年 发布于
J Cancer Res Ther
45 卷 第 15 期
Lin Y.
Wang Y.
Wu Q.
Jin H.
Ma G.
Liu H.
Wang M.
Zhang Z.
Chu H.
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Chemotherapy
Adjuvant
Cisplatin/administration & dosage
*Cystectomy/methods
Evidence-Based Medicine
Humans
*Lymph Node Excision
Neoadjuvant Therapy/*methods
Neoplasm Invasiveness
Organ Sparing Treatments
/methods
Randomized Controlled Trials as Topic
Survival Analysis
Treatment Outcome
Urinary Bladder Neoplasms/mortality/*pathology/*therapy
adjuvant chemotherapy
bladder cancer
bladder-sparing therapy
lymph node dissection
neoadjuvant chemotherapy
radical cystectomy
文献简介
原文链接